nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CA5A—glaucoma	0.242	0.71	CbGaD
Indapamide—CA2—glaucoma	0.0989	0.29	CbGaD
Indapamide—CA5A—Brinzolamide—glaucoma	0.0191	0.0397	CbGbCtD
Indapamide—CA5A—Diclofenamide—glaucoma	0.0191	0.0397	CbGbCtD
Indapamide—CA5A—Dorzolamide—glaucoma	0.0185	0.0384	CbGbCtD
Indapamide—CA5B—Brinzolamide—glaucoma	0.0167	0.0346	CbGbCtD
Indapamide—CA7—Diclofenamide—glaucoma	0.0167	0.0346	CbGbCtD
Indapamide—CA5B—Diclofenamide—glaucoma	0.0167	0.0346	CbGbCtD
Indapamide—CA7—Brinzolamide—glaucoma	0.0167	0.0346	CbGbCtD
Indapamide—CA5A—Methazolamide—glaucoma	0.0165	0.0342	CbGbCtD
Indapamide—CA7—Dorzolamide—glaucoma	0.0161	0.0334	CbGbCtD
Indapamide—CA5B—Dorzolamide—glaucoma	0.0161	0.0334	CbGbCtD
Indapamide—CA5B—Methazolamide—glaucoma	0.0143	0.0298	CbGbCtD
Indapamide—CA7—Methazolamide—glaucoma	0.0143	0.0298	CbGbCtD
Indapamide—CA12—Brinzolamide—glaucoma	0.0143	0.0297	CbGbCtD
Indapamide—CA9—Brinzolamide—glaucoma	0.0143	0.0297	CbGbCtD
Indapamide—CA9—Diclofenamide—glaucoma	0.0143	0.0297	CbGbCtD
Indapamide—CA12—Diclofenamide—glaucoma	0.0143	0.0297	CbGbCtD
Indapamide—KCNE1—cornea—glaucoma	0.014	0.791	CbGeAlD
Indapamide—CA9—Dorzolamide—glaucoma	0.0138	0.0287	CbGbCtD
Indapamide—CA12—Dorzolamide—glaucoma	0.0138	0.0287	CbGbCtD
Indapamide—CA5A—Acetazolamide—glaucoma	0.0132	0.0273	CbGbCtD
Indapamide—CA4—Brinzolamide—glaucoma	0.0126	0.0261	CbGbCtD
Indapamide—CA4—Diclofenamide—glaucoma	0.0126	0.0261	CbGbCtD
Indapamide—CA9—Methazolamide—glaucoma	0.0123	0.0256	CbGbCtD
Indapamide—CA12—Methazolamide—glaucoma	0.0123	0.0256	CbGbCtD
Indapamide—CA4—Dorzolamide—glaucoma	0.0122	0.0252	CbGbCtD
Indapamide—CA2—Brinzolamide—glaucoma	0.0116	0.024	CbGbCtD
Indapamide—CA2—Diclofenamide—glaucoma	0.0116	0.024	CbGbCtD
Indapamide—CA5B—Acetazolamide—glaucoma	0.0115	0.0238	CbGbCtD
Indapamide—CA7—Acetazolamide—glaucoma	0.0115	0.0238	CbGbCtD
Indapamide—CA2—Dorzolamide—glaucoma	0.0112	0.0232	CbGbCtD
Indapamide—CA4—Methazolamide—glaucoma	0.0108	0.0225	CbGbCtD
Indapamide—CA2—Methazolamide—glaucoma	0.00996	0.0207	CbGbCtD
Indapamide—CA12—Acetazolamide—glaucoma	0.00985	0.0205	CbGbCtD
Indapamide—CA9—Acetazolamide—glaucoma	0.00985	0.0205	CbGbCtD
Indapamide—CA4—Acetazolamide—glaucoma	0.00866	0.018	CbGbCtD
Indapamide—CA2—Acetazolamide—glaucoma	0.00796	0.0165	CbGbCtD
Indapamide—CA5B—Reversible hydration of carbon dioxide—CA5A—glaucoma	0.00444	0.0757	CbGpPWpGaD
Indapamide—CA7—Reversible hydration of carbon dioxide—CA5A—glaucoma	0.00444	0.0757	CbGpPWpGaD
Indapamide—CA12—Reversible hydration of carbon dioxide—CA5A—glaucoma	0.00412	0.0701	CbGpPWpGaD
Indapamide—CA4—Reversible hydration of carbon dioxide—CA5A—glaucoma	0.00328	0.0559	CbGpPWpGaD
Indapamide—CA2—Reversible hydration of carbon dioxide—CA5A—glaucoma	0.00315	0.0536	CbGpPWpGaD
Indapamide—CA9—Reversible hydration of carbon dioxide—CA5A—glaucoma	0.00265	0.0452	CbGpPWpGaD
Indapamide—CA5A—Reversible hydration of carbon dioxide—CA1—glaucoma	0.00232	0.0396	CbGpPWpGaD
Indapamide—CA5B—Reversible hydration of carbon dioxide—CA1—glaucoma	0.00217	0.037	CbGpPWpGaD
Indapamide—CA7—Reversible hydration of carbon dioxide—CA1—glaucoma	0.00217	0.037	CbGpPWpGaD
Indapamide—CA5A—Reversible hydration of carbon dioxide—CA2—glaucoma	0.00213	0.0362	CbGpPWpGaD
Indapamide—CA4—Erythrocytes take up carbon dioxide and release oxygen—CA1—glaucoma	0.00202	0.0344	CbGpPWpGaD
Indapamide—CA12—Reversible hydration of carbon dioxide—CA1—glaucoma	0.00201	0.0342	CbGpPWpGaD
Indapamide—CA5B—Reversible hydration of carbon dioxide—CA2—glaucoma	0.00199	0.0338	CbGpPWpGaD
Indapamide—CA7—Reversible hydration of carbon dioxide—CA2—glaucoma	0.00199	0.0338	CbGpPWpGaD
Indapamide—CA2—Erythrocytes take up carbon dioxide and release oxygen—CA1—glaucoma	0.00194	0.033	CbGpPWpGaD
Indapamide—CA4—Erythrocytes take up carbon dioxide and release oxygen—CA2—glaucoma	0.00185	0.0314	CbGpPWpGaD
Indapamide—CA12—Reversible hydration of carbon dioxide—CA2—glaucoma	0.00184	0.0313	CbGpPWpGaD
Indapamide—KCNE1—eye—glaucoma	0.00172	0.0975	CbGeAlD
Indapamide—CA4—Reversible hydration of carbon dioxide—CA1—glaucoma	0.0016	0.0273	CbGpPWpGaD
Indapamide—CA2—Reversible hydration of carbon dioxide—CA1—glaucoma	0.00154	0.0262	CbGpPWpGaD
Indapamide—CYP3A4—Pilocarpine—glaucoma	0.00151	0.00315	CbGbCtD
Indapamide—CA4—Reversible hydration of carbon dioxide—CA2—glaucoma	0.00147	0.025	CbGpPWpGaD
Indapamide—CA9—Reversible hydration of carbon dioxide—CA1—glaucoma	0.0013	0.0221	CbGpPWpGaD
Indapamide—CYP3A4—Brinzolamide—glaucoma	0.00119	0.00247	CbGbCtD
Indapamide—CA9—Reversible hydration of carbon dioxide—CA2—glaucoma	0.00119	0.0202	CbGpPWpGaD
Indapamide—CYP3A4—Dorzolamide—glaucoma	0.00115	0.00238	CbGbCtD
Indapamide—CYP3A4—Methazolamide—glaucoma	0.00102	0.00212	CbGbCtD
Indapamide—CYP3A4—Acetazolamide—glaucoma	0.000817	0.0017	CbGbCtD
Indapamide—CYP3A4—Clonidine—glaucoma	0.000739	0.00154	CbGbCtD
Indapamide—Furosemide—CA5A—glaucoma	0.000644	0.192	CrCbGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000628	0.0107	CbGpPWpGaD
Indapamide—Metolazone—CA5A—glaucoma	0.000618	0.184	CrCbGaD
Indapamide—CA12—eye—glaucoma	0.000563	0.0319	CbGeAlD
Indapamide—CA12—connective tissue—glaucoma	0.000542	0.0308	CbGeAlD
Indapamide—Bumetanide—CA5A—glaucoma	0.000488	0.145	CrCbGaD
Indapamide—Chlorthalidone—CA5A—glaucoma	0.000478	0.143	CrCbGaD
Indapamide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A4—glaucoma	0.000418	0.00711	CbGpPWpGaD
Indapamide—Furosemide—CA1—glaucoma	0.000347	0.103	CrCbGaD
Indapamide—CA2—eye—glaucoma	0.000289	0.0164	CbGeAlD
Indapamide—CA2—retina—glaucoma	0.000286	0.0162	CbGeAlD
Indapamide—CA2—connective tissue—glaucoma	0.000279	0.0158	CbGeAlD
Indapamide—Furosemide—CA2—glaucoma	0.000263	0.0784	CrCbGaD
Indapamide—Chlorthalidone—CA1—glaucoma	0.000258	0.0768	CrCbGaD
Indapamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—glaucoma	0.000231	0.00393	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000225	0.00383	CbGpPWpGaD
Indapamide—Chlorthalidone—CA2—glaucoma	0.000195	0.0582	CrCbGaD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000187	0.00318	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—SLC6A13—glaucoma	0.000178	0.00303	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000161	0.00274	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—PEX19—glaucoma	0.00014	0.00239	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—SLC6A1—glaucoma	0.00013	0.00222	CbGpPWpGaD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000125	0.00212	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00012	0.00205	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000115	0.00197	CbGpPWpGaD
Indapamide—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000109	0.00186	CbGpPWpGaD
Indapamide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000107	0.00182	CbGpPWpGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000107	0.00182	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—NGF—glaucoma	0.000107	0.00182	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000106	0.00181	CbGpPWpGaD
Indapamide—CA9—Cellular response to hypoxia—VEGFA—glaucoma	0.000102	0.00173	CbGpPWpGaD
Indapamide—CA5A—Metabolism—NARFL—glaucoma	9.67e-05	0.00165	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC4A4—glaucoma	9.48e-05	0.00162	CbGpPWpGaD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	9.11e-05	0.00155	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NARFL—glaucoma	9.03e-05	0.00154	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CA5A—glaucoma	9.03e-05	0.00154	CbGpPWpGaD
Indapamide—CA7—Metabolism—NARFL—glaucoma	9.03e-05	0.00154	CbGpPWpGaD
Indapamide—CA7—Metabolism—CA5A—glaucoma	9.03e-05	0.00154	CbGpPWpGaD
Indapamide—CA12—Metabolism—CA5A—glaucoma	8.37e-05	0.00143	CbGpPWpGaD
Indapamide—CA12—Metabolism—NARFL—glaucoma	8.37e-05	0.00143	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—RPTOR—glaucoma	8.28e-05	0.00141	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—TXN—glaucoma	7.04e-05	0.0012	CbGpPWpGaD
Indapamide—CA4—Metabolism—NARFL—glaucoma	6.67e-05	0.00114	CbGpPWpGaD
Indapamide—CA4—Metabolism—CA5A—glaucoma	6.67e-05	0.00114	CbGpPWpGaD
Indapamide—CA2—Metabolism—NARFL—glaucoma	6.4e-05	0.00109	CbGpPWpGaD
Indapamide—CA2—Metabolism—CA5A—glaucoma	6.4e-05	0.00109	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.33e-05	0.00108	CbGpPWpGaD
Indapamide—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	6.28e-05	0.00107	CbGpPWpGaD
Indapamide—Bumetanide—PTGS2—glaucoma	6.25e-05	0.0186	CrCbGaD
Indapamide—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	5.55e-05	0.000945	CbGpPWpGaD
Indapamide—CA9—Metabolism—CA5A—glaucoma	5.39e-05	0.000918	CbGpPWpGaD
Indapamide—CA9—Metabolism—NARFL—glaucoma	5.39e-05	0.000918	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—VEGFA—glaucoma	5.09e-05	0.000868	CbGpPWpGaD
Indapamide—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	5.02e-05	0.000855	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CA1—glaucoma	4.72e-05	0.000805	CbGpPWpGaD
Indapamide—Depression—Timolol—glaucoma	4.7e-05	0.00048	CcSEcCtD
Indapamide—Pruritus—Bimatoprost—glaucoma	4.68e-05	0.000478	CcSEcCtD
Indapamide—CA9—HIF-1-alpha transcription factor network—VEGFA—glaucoma	4.68e-05	0.000798	CbGpPWpGaD
Indapamide—Diarrhoea—Apraclonidine—glaucoma	4.67e-05	0.000477	CcSEcCtD
Indapamide—Malaise—Clonidine—glaucoma	4.67e-05	0.000477	CcSEcCtD
Indapamide—Dyspepsia—Pilocarpine—glaucoma	4.66e-05	0.000476	CcSEcCtD
Indapamide—Syncope—Clonidine—glaucoma	4.64e-05	0.000474	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.63e-05	0.000789	CbGpPWpGaD
Indapamide—Arrhythmia—Betaxolol—glaucoma	4.63e-05	0.000472	CcSEcCtD
Indapamide—Feeling abnormal—Dorzolamide—glaucoma	4.61e-05	0.000471	CcSEcCtD
Indapamide—Decreased appetite—Pilocarpine—glaucoma	4.6e-05	0.00047	CcSEcCtD
Indapamide—Feeling abnormal—Travoprost—glaucoma	4.59e-05	0.000469	CcSEcCtD
Indapamide—Conjunctivitis—Timolol—glaucoma	4.58e-05	0.000468	CcSEcCtD
Indapamide—Gastrointestinal pain—Dorzolamide—glaucoma	4.58e-05	0.000468	CcSEcCtD
Indapamide—CA5A—Metabolism—CTSA—glaucoma	4.58e-05	0.000779	CbGpPWpGaD
Indapamide—Palpitations—Clonidine—glaucoma	4.57e-05	0.000467	CcSEcCtD
Indapamide—Gastrointestinal disorder—Pilocarpine—glaucoma	4.57e-05	0.000466	CcSEcCtD
Indapamide—Gastrointestinal pain—Travoprost—glaucoma	4.56e-05	0.000466	CcSEcCtD
Indapamide—Loss of consciousness—Clonidine—glaucoma	4.55e-05	0.000465	CcSEcCtD
Indapamide—Feeling abnormal—Brinzolamide—glaucoma	4.54e-05	0.000463	CcSEcCtD
Indapamide—Pain—Pilocarpine—glaucoma	4.52e-05	0.000462	CcSEcCtD
Indapamide—Constipation—Pilocarpine—glaucoma	4.52e-05	0.000462	CcSEcCtD
Indapamide—Cough—Clonidine—glaucoma	4.52e-05	0.000461	CcSEcCtD
Indapamide—Sweating—Timolol—glaucoma	4.52e-05	0.000461	CcSEcCtD
Indapamide—Dizziness—Apraclonidine—glaucoma	4.52e-05	0.000461	CcSEcCtD
Indapamide—Malnutrition—Betaxolol—glaucoma	4.51e-05	0.00046	CcSEcCtD
Indapamide—Erythema—Betaxolol—glaucoma	4.51e-05	0.00046	CcSEcCtD
Indapamide—Urticaria—Dorzolamide—glaucoma	4.45e-05	0.000454	CcSEcCtD
Indapamide—Abdominal pain—Dorzolamide—glaucoma	4.43e-05	0.000452	CcSEcCtD
Indapamide—Body temperature increased—Dorzolamide—glaucoma	4.43e-05	0.000452	CcSEcCtD
Indapamide—Tension—Betaxolol—glaucoma	4.42e-05	0.000452	CcSEcCtD
Indapamide—Sinusitis—Timolol—glaucoma	4.42e-05	0.000451	CcSEcCtD
Indapamide—Dysgeusia—Betaxolol—glaucoma	4.41e-05	0.000451	CcSEcCtD
Indapamide—CA5B—Metabolism—CA1—glaucoma	4.41e-05	0.000751	CbGpPWpGaD
Indapamide—CA7—Metabolism—CA1—glaucoma	4.41e-05	0.000751	CbGpPWpGaD
Indapamide—Arthralgia—Clonidine—glaucoma	4.41e-05	0.00045	CcSEcCtD
Indapamide—Chest pain—Clonidine—glaucoma	4.41e-05	0.00045	CcSEcCtD
Indapamide—Abdominal pain—Travoprost—glaucoma	4.41e-05	0.00045	CcSEcCtD
Indapamide—Agranulocytosis—Timolol—glaucoma	4.4e-05	0.000449	CcSEcCtD
Indapamide—Anxiety—Clonidine—glaucoma	4.39e-05	0.000449	CcSEcCtD
Indapamide—Asthenia—Acetazolamide—glaucoma	4.38e-05	0.000448	CcSEcCtD
Indapamide—Dizziness—Bimatoprost—glaucoma	4.38e-05	0.000447	CcSEcCtD
Indapamide—Nervousness—Betaxolol—glaucoma	4.38e-05	0.000447	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	4.38e-05	0.000447	CcSEcCtD
Indapamide—Urticaria—Brinzolamide—glaucoma	4.37e-05	0.000447	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—TNF—glaucoma	4.37e-05	0.000744	CbGpPWpGaD
Indapamide—Feeling abnormal—Pilocarpine—glaucoma	4.36e-05	0.000445	CcSEcCtD
Indapamide—Discomfort—Clonidine—glaucoma	4.35e-05	0.000445	CcSEcCtD
Indapamide—Vomiting—Apraclonidine—glaucoma	4.34e-05	0.000443	CcSEcCtD
Indapamide—Muscle spasms—Betaxolol—glaucoma	4.33e-05	0.000442	CcSEcCtD
Indapamide—Gastrointestinal pain—Pilocarpine—glaucoma	4.33e-05	0.000442	CcSEcCtD
Indapamide—CA5A—Metabolism—CA2—glaucoma	4.32e-05	0.000736	CbGpPWpGaD
Indapamide—Hypersensitivity—Brimonidine—glaucoma	4.32e-05	0.000441	CcSEcCtD
Indapamide—Dry mouth—Clonidine—glaucoma	4.31e-05	0.00044	CcSEcCtD
Indapamide—Dermatitis—Apraclonidine—glaucoma	4.3e-05	0.000439	CcSEcCtD
Indapamide—Headache—Apraclonidine—glaucoma	4.28e-05	0.000437	CcSEcCtD
Indapamide—CA5B—Metabolism—CTSA—glaucoma	4.27e-05	0.000728	CbGpPWpGaD
Indapamide—CA7—Metabolism—CTSA—glaucoma	4.27e-05	0.000728	CbGpPWpGaD
Indapamide—Vision blurred—Betaxolol—glaucoma	4.25e-05	0.000434	CcSEcCtD
Indapamide—Rhinitis—Timolol—glaucoma	4.24e-05	0.000433	CcSEcCtD
Indapamide—Oedema—Clonidine—glaucoma	4.22e-05	0.000431	CcSEcCtD
Indapamide—Asthenia—Brimonidine—glaucoma	4.21e-05	0.00043	CcSEcCtD
Indapamide—Infection—Clonidine—glaucoma	4.2e-05	0.000429	CcSEcCtD
Indapamide—Body temperature increased—Pilocarpine—glaucoma	4.18e-05	0.000427	CcSEcCtD
Indapamide—Abdominal pain—Pilocarpine—glaucoma	4.18e-05	0.000427	CcSEcCtD
Indapamide—Ill-defined disorder—Betaxolol—glaucoma	4.18e-05	0.000427	CcSEcCtD
Indapamide—Diarrhoea—Acetazolamide—glaucoma	4.18e-05	0.000427	CcSEcCtD
Indapamide—Rash—Bimatoprost—glaucoma	4.17e-05	0.000426	CcSEcCtD
Indapamide—Dermatitis—Bimatoprost—glaucoma	4.17e-05	0.000426	CcSEcCtD
Indapamide—Oedema peripheral—Timolol—glaucoma	4.17e-05	0.000425	CcSEcCtD
Indapamide—Anaemia—Betaxolol—glaucoma	4.17e-05	0.000425	CcSEcCtD
Indapamide—Shock—Clonidine—glaucoma	4.16e-05	0.000424	CcSEcCtD
Indapamide—Pruritus—Brimonidine—glaucoma	4.15e-05	0.000424	CcSEcCtD
Indapamide—Headache—Bimatoprost—glaucoma	4.15e-05	0.000424	CcSEcCtD
Indapamide—Nervous system disorder—Clonidine—glaucoma	4.14e-05	0.000423	CcSEcCtD
Indapamide—Thrombocytopenia—Clonidine—glaucoma	4.14e-05	0.000422	CcSEcCtD
Indapamide—Hypersensitivity—Dorzolamide—glaucoma	4.13e-05	0.000421	CcSEcCtD
Indapamide—Tachycardia—Clonidine—glaucoma	4.12e-05	0.000421	CcSEcCtD
Indapamide—Hypersensitivity—Travoprost—glaucoma	4.11e-05	0.000419	CcSEcCtD
Indapamide—Skin disorder—Clonidine—glaucoma	4.1e-05	0.000419	CcSEcCtD
Indapamide—CA12—Metabolism—CA1—glaucoma	4.09e-05	0.000696	CbGpPWpGaD
Indapamide—Hyperhidrosis—Clonidine—glaucoma	4.08e-05	0.000417	CcSEcCtD
Indapamide—Visual impairment—Timolol—glaucoma	4.08e-05	0.000416	CcSEcCtD
Indapamide—Malaise—Betaxolol—glaucoma	4.06e-05	0.000415	CcSEcCtD
Indapamide—Nausea—Apraclonidine—glaucoma	4.06e-05	0.000414	CcSEcCtD
Indapamide—Hypersensitivity—Brinzolamide—glaucoma	4.06e-05	0.000414	CcSEcCtD
Indapamide—Vertigo—Betaxolol—glaucoma	4.05e-05	0.000414	CcSEcCtD
Indapamide—Syncope—Betaxolol—glaucoma	4.04e-05	0.000413	CcSEcCtD
Indapamide—Dizziness—Acetazolamide—glaucoma	4.04e-05	0.000413	CcSEcCtD
Indapamide—CA5B—Metabolism—CA2—glaucoma	4.03e-05	0.000687	CbGpPWpGaD
Indapamide—CA7—Metabolism—CA2—glaucoma	4.03e-05	0.000687	CbGpPWpGaD
Indapamide—Anorexia—Clonidine—glaucoma	4.03e-05	0.000411	CcSEcCtD
Indapamide—Asthenia—Dorzolamide—glaucoma	4.02e-05	0.00041	CcSEcCtD
Indapamide—Asthenia—Travoprost—glaucoma	4e-05	0.000408	CcSEcCtD
Indapamide—Palpitations—Betaxolol—glaucoma	3.98e-05	0.000407	CcSEcCtD
Indapamide—Pruritus—Dorzolamide—glaucoma	3.96e-05	0.000405	CcSEcCtD
Indapamide—Loss of consciousness—Betaxolol—glaucoma	3.96e-05	0.000405	CcSEcCtD
Indapamide—CA12—Metabolism—CTSA—glaucoma	3.96e-05	0.000674	CbGpPWpGaD
Indapamide—Asthenia—Brinzolamide—glaucoma	3.95e-05	0.000403	CcSEcCtD
Indapamide—Hypotension—Clonidine—glaucoma	3.95e-05	0.000403	CcSEcCtD
Indapamide—Pruritus—Travoprost—glaucoma	3.94e-05	0.000403	CcSEcCtD
Indapamide—Tinnitus—Timolol—glaucoma	3.94e-05	0.000403	CcSEcCtD
Indapamide—Cough—Betaxolol—glaucoma	3.93e-05	0.000402	CcSEcCtD
Indapamide—Nausea—Bimatoprost—glaucoma	3.93e-05	0.000402	CcSEcCtD
Indapamide—Cardiac disorder—Timolol—glaucoma	3.93e-05	0.000401	CcSEcCtD
Indapamide—Hypersensitivity—Pilocarpine—glaucoma	3.9e-05	0.000398	CcSEcCtD
Indapamide—Pruritus—Brinzolamide—glaucoma	3.89e-05	0.000398	CcSEcCtD
Indapamide—Vomiting—Acetazolamide—glaucoma	3.88e-05	0.000397	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—SOD1—glaucoma	3.88e-05	0.000661	CbGpPWpGaD
Indapamide—Dizziness—Brimonidine—glaucoma	3.88e-05	0.000396	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Clonidine—glaucoma	3.85e-05	0.000393	CcSEcCtD
Indapamide—Chest pain—Betaxolol—glaucoma	3.84e-05	0.000392	CcSEcCtD
Indapamide—Myalgia—Betaxolol—glaucoma	3.84e-05	0.000392	CcSEcCtD
Indapamide—Arthralgia—Betaxolol—glaucoma	3.84e-05	0.000392	CcSEcCtD
Indapamide—Diarrhoea—Dorzolamide—glaucoma	3.83e-05	0.000391	CcSEcCtD
Indapamide—Headache—Acetazolamide—glaucoma	3.83e-05	0.000391	CcSEcCtD
Indapamide—Anxiety—Betaxolol—glaucoma	3.82e-05	0.00039	CcSEcCtD
Indapamide—Insomnia—Clonidine—glaucoma	3.82e-05	0.00039	CcSEcCtD
Indapamide—Diarrhoea—Travoprost—glaucoma	3.81e-05	0.00039	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	3.81e-05	0.000389	CcSEcCtD
Indapamide—Asthenia—Pilocarpine—glaucoma	3.8e-05	0.000388	CcSEcCtD
Indapamide—Paraesthesia—Clonidine—glaucoma	3.79e-05	0.000387	CcSEcCtD
Indapamide—Discomfort—Betaxolol—glaucoma	3.79e-05	0.000387	CcSEcCtD
Indapamide—Arrhythmia—Timolol—glaucoma	3.78e-05	0.000386	CcSEcCtD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	3.77e-05	0.000643	CbGpPWpGaD
Indapamide—Dyspnoea—Clonidine—glaucoma	3.77e-05	0.000385	CcSEcCtD
Indapamide—Diarrhoea—Brinzolamide—glaucoma	3.77e-05	0.000385	CcSEcCtD
Indapamide—Somnolence—Clonidine—glaucoma	3.76e-05	0.000384	CcSEcCtD
Indapamide—Dry mouth—Betaxolol—glaucoma	3.75e-05	0.000383	CcSEcCtD
Indapamide—Pruritus—Pilocarpine—glaucoma	3.74e-05	0.000382	CcSEcCtD
Indapamide—CA12—Metabolism—CA2—glaucoma	3.74e-05	0.000637	CbGpPWpGaD
Indapamide—Dizziness—Dorzolamide—glaucoma	3.7e-05	0.000378	CcSEcCtD
Indapamide—Rash—Brimonidine—glaucoma	3.7e-05	0.000377	CcSEcCtD
Indapamide—Dermatitis—Brimonidine—glaucoma	3.69e-05	0.000377	CcSEcCtD
Indapamide—Dizziness—Travoprost—glaucoma	3.69e-05	0.000376	CcSEcCtD
Indapamide—Malnutrition—Timolol—glaucoma	3.68e-05	0.000376	CcSEcCtD
Indapamide—Erythema—Timolol—glaucoma	3.68e-05	0.000376	CcSEcCtD
Indapamide—Oedema—Betaxolol—glaucoma	3.68e-05	0.000376	CcSEcCtD
Indapamide—Headache—Brimonidine—glaucoma	3.67e-05	0.000375	CcSEcCtD
Indapamide—Decreased appetite—Clonidine—glaucoma	3.67e-05	0.000375	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—CDKN2B—glaucoma	3.67e-05	0.000625	CbGpPWpGaD
Indapamide—Infection—Betaxolol—glaucoma	3.65e-05	0.000373	CcSEcCtD
Indapamide—Gastrointestinal disorder—Clonidine—glaucoma	3.65e-05	0.000372	CcSEcCtD
Indapamide—Fatigue—Clonidine—glaucoma	3.64e-05	0.000372	CcSEcCtD
Indapamide—Dizziness—Brinzolamide—glaucoma	3.64e-05	0.000372	CcSEcCtD
Indapamide—Nausea—Acetazolamide—glaucoma	3.63e-05	0.000371	CcSEcCtD
Indapamide—Diarrhoea—Pilocarpine—glaucoma	3.62e-05	0.00037	CcSEcCtD
Indapamide—Shock—Betaxolol—glaucoma	3.62e-05	0.00037	CcSEcCtD
Indapamide—Tension—Timolol—glaucoma	3.61e-05	0.000369	CcSEcCtD
Indapamide—Pain—Clonidine—glaucoma	3.61e-05	0.000369	CcSEcCtD
Indapamide—Constipation—Clonidine—glaucoma	3.61e-05	0.000369	CcSEcCtD
Indapamide—Nervous system disorder—Betaxolol—glaucoma	3.61e-05	0.000368	CcSEcCtD
Indapamide—Dysgeusia—Timolol—glaucoma	3.61e-05	0.000368	CcSEcCtD
Indapamide—Thrombocytopenia—Betaxolol—glaucoma	3.6e-05	0.000368	CcSEcCtD
Indapamide—Tachycardia—Betaxolol—glaucoma	3.59e-05	0.000367	CcSEcCtD
Indapamide—Nervousness—Timolol—glaucoma	3.58e-05	0.000365	CcSEcCtD
Indapamide—Skin disorder—Betaxolol—glaucoma	3.57e-05	0.000365	CcSEcCtD
Indapamide—Vomiting—Dorzolamide—glaucoma	3.56e-05	0.000364	CcSEcCtD
Indapamide—Hyperhidrosis—Betaxolol—glaucoma	3.56e-05	0.000363	CcSEcCtD
Indapamide—Rash—Dorzolamide—glaucoma	3.53e-05	0.000361	CcSEcCtD
Indapamide—Dermatitis—Dorzolamide—glaucoma	3.53e-05	0.00036	CcSEcCtD
Indapamide—Rash—Travoprost—glaucoma	3.52e-05	0.000359	CcSEcCtD
Indapamide—Dermatitis—Travoprost—glaucoma	3.51e-05	0.000359	CcSEcCtD
Indapamide—Headache—Dorzolamide—glaucoma	3.51e-05	0.000358	CcSEcCtD
Indapamide—Anorexia—Betaxolol—glaucoma	3.51e-05	0.000358	CcSEcCtD
Indapamide—Vomiting—Brinzolamide—glaucoma	3.5e-05	0.000357	CcSEcCtD
Indapamide—Dizziness—Pilocarpine—glaucoma	3.5e-05	0.000357	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—IL1A—glaucoma	3.5e-05	0.000596	CbGpPWpGaD
Indapamide—Headache—Travoprost—glaucoma	3.49e-05	0.000357	CcSEcCtD
Indapamide—Nausea—Brimonidine—glaucoma	3.48e-05	0.000356	CcSEcCtD
Indapamide—Feeling abnormal—Clonidine—glaucoma	3.48e-05	0.000356	CcSEcCtD
Indapamide—Rash—Brinzolamide—glaucoma	3.47e-05	0.000354	CcSEcCtD
Indapamide—Vision blurred—Timolol—glaucoma	3.47e-05	0.000354	CcSEcCtD
Indapamide—Dermatitis—Brinzolamide—glaucoma	3.47e-05	0.000354	CcSEcCtD
Indapamide—Gastrointestinal pain—Clonidine—glaucoma	3.45e-05	0.000353	CcSEcCtD
Indapamide—Headache—Brinzolamide—glaucoma	3.45e-05	0.000352	CcSEcCtD
Indapamide—Hypotension—Betaxolol—glaucoma	3.44e-05	0.000351	CcSEcCtD
Indapamide—Angioedema—Timolol—glaucoma	3.36e-05	0.000344	CcSEcCtD
Indapamide—Vomiting—Pilocarpine—glaucoma	3.36e-05	0.000344	CcSEcCtD
Indapamide—Urticaria—Clonidine—glaucoma	3.36e-05	0.000343	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Betaxolol—glaucoma	3.35e-05	0.000342	CcSEcCtD
Indapamide—Abdominal pain—Clonidine—glaucoma	3.34e-05	0.000341	CcSEcCtD
Indapamide—Body temperature increased—Clonidine—glaucoma	3.34e-05	0.000341	CcSEcCtD
Indapamide—Rash—Pilocarpine—glaucoma	3.34e-05	0.000341	CcSEcCtD
Indapamide—Dermatitis—Pilocarpine—glaucoma	3.33e-05	0.00034	CcSEcCtD
Indapamide—Insomnia—Betaxolol—glaucoma	3.33e-05	0.00034	CcSEcCtD
Indapamide—Nausea—Dorzolamide—glaucoma	3.33e-05	0.00034	CcSEcCtD
Indapamide—Headache—Pilocarpine—glaucoma	3.31e-05	0.000338	CcSEcCtD
Indapamide—Nausea—Travoprost—glaucoma	3.31e-05	0.000338	CcSEcCtD
Indapamide—Vertigo—Timolol—glaucoma	3.31e-05	0.000338	CcSEcCtD
Indapamide—Paraesthesia—Betaxolol—glaucoma	3.3e-05	0.000337	CcSEcCtD
Indapamide—Syncope—Timolol—glaucoma	3.3e-05	0.000337	CcSEcCtD
Indapamide—Dyspnoea—Betaxolol—glaucoma	3.28e-05	0.000335	CcSEcCtD
Indapamide—Nausea—Brinzolamide—glaucoma	3.27e-05	0.000334	CcSEcCtD
Indapamide—CA4—Metabolism—CA1—glaucoma	3.26e-05	0.000555	CbGpPWpGaD
Indapamide—Palpitations—Timolol—glaucoma	3.25e-05	0.000332	CcSEcCtD
Indapamide—Dyspepsia—Betaxolol—glaucoma	3.24e-05	0.000331	CcSEcCtD
Indapamide—Loss of consciousness—Timolol—glaucoma	3.24e-05	0.00033	CcSEcCtD
Indapamide—Cough—Timolol—glaucoma	3.21e-05	0.000328	CcSEcCtD
Indapamide—Decreased appetite—Betaxolol—glaucoma	3.2e-05	0.000327	CcSEcCtD
Indapamide—Gastrointestinal disorder—Betaxolol—glaucoma	3.18e-05	0.000324	CcSEcCtD
Indapamide—Fatigue—Betaxolol—glaucoma	3.17e-05	0.000324	CcSEcCtD
Indapamide—CA4—Metabolism—CTSA—glaucoma	3.16e-05	0.000538	CbGpPWpGaD
Indapamide—Pain—Betaxolol—glaucoma	3.15e-05	0.000321	CcSEcCtD
Indapamide—Constipation—Betaxolol—glaucoma	3.15e-05	0.000321	CcSEcCtD
Indapamide—Nausea—Pilocarpine—glaucoma	3.14e-05	0.000321	CcSEcCtD
Indapamide—Chest pain—Timolol—glaucoma	3.13e-05	0.00032	CcSEcCtD
Indapamide—Myalgia—Timolol—glaucoma	3.13e-05	0.00032	CcSEcCtD
Indapamide—Arthralgia—Timolol—glaucoma	3.13e-05	0.00032	CcSEcCtD
Indapamide—CA2—Metabolism—CA1—glaucoma	3.12e-05	0.000532	CbGpPWpGaD
Indapamide—Anxiety—Timolol—glaucoma	3.12e-05	0.000319	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	3.11e-05	0.000318	CcSEcCtD
Indapamide—Hypersensitivity—Clonidine—glaucoma	3.11e-05	0.000318	CcSEcCtD
Indapamide—Discomfort—Timolol—glaucoma	3.1e-05	0.000316	CcSEcCtD
Indapamide—Dry mouth—Timolol—glaucoma	3.07e-05	0.000313	CcSEcCtD
Indapamide—CA5A—Metabolism—TXN—glaucoma	3.04e-05	0.000519	CbGpPWpGaD
Indapamide—Asthenia—Clonidine—glaucoma	3.03e-05	0.00031	CcSEcCtD
Indapamide—Feeling abnormal—Betaxolol—glaucoma	3.03e-05	0.00031	CcSEcCtD
Indapamide—CA2—Metabolism—CTSA—glaucoma	3.03e-05	0.000515	CbGpPWpGaD
Indapamide—Oedema—Timolol—glaucoma	3e-05	0.000307	CcSEcCtD
Indapamide—Anaphylactic shock—Timolol—glaucoma	3e-05	0.000307	CcSEcCtD
Indapamide—Pruritus—Clonidine—glaucoma	2.99e-05	0.000305	CcSEcCtD
Indapamide—Infection—Timolol—glaucoma	2.99e-05	0.000305	CcSEcCtD
Indapamide—CA4—Metabolism—CA2—glaucoma	2.98e-05	0.000508	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	2.96e-05	0.000505	CbGpPWpGaD
Indapamide—Shock—Timolol—glaucoma	2.96e-05	0.000302	CcSEcCtD
Indapamide—Nervous system disorder—Timolol—glaucoma	2.95e-05	0.000301	CcSEcCtD
Indapamide—Urticaria—Betaxolol—glaucoma	2.92e-05	0.000298	CcSEcCtD
Indapamide—Skin disorder—Timolol—glaucoma	2.92e-05	0.000298	CcSEcCtD
Indapamide—Body temperature increased—Betaxolol—glaucoma	2.91e-05	0.000297	CcSEcCtD
Indapamide—Hyperhidrosis—Timolol—glaucoma	2.9e-05	0.000297	CcSEcCtD
Indapamide—Diarrhoea—Clonidine—glaucoma	2.89e-05	0.000295	CcSEcCtD
Indapamide—Anorexia—Timolol—glaucoma	2.86e-05	0.000293	CcSEcCtD
Indapamide—CA5B—Metabolism—TXN—glaucoma	2.84e-05	0.000484	CbGpPWpGaD
Indapamide—CA7—Metabolism—TXN—glaucoma	2.84e-05	0.000484	CbGpPWpGaD
Indapamide—Hypotension—Timolol—glaucoma	2.81e-05	0.000287	CcSEcCtD
Indapamide—Dizziness—Clonidine—glaucoma	2.79e-05	0.000285	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Timolol—glaucoma	2.74e-05	0.00028	CcSEcCtD
Indapamide—Insomnia—Timolol—glaucoma	2.72e-05	0.000278	CcSEcCtD
Indapamide—Hypersensitivity—Betaxolol—glaucoma	2.71e-05	0.000277	CcSEcCtD
Indapamide—Paraesthesia—Timolol—glaucoma	2.7e-05	0.000276	CcSEcCtD
Indapamide—Vomiting—Clonidine—glaucoma	2.69e-05	0.000274	CcSEcCtD
Indapamide—Dyspnoea—Timolol—glaucoma	2.68e-05	0.000274	CcSEcCtD
Indapamide—Somnolence—Timolol—glaucoma	2.67e-05	0.000273	CcSEcCtD
Indapamide—Rash—Clonidine—glaucoma	2.66e-05	0.000272	CcSEcCtD
Indapamide—Dermatitis—Clonidine—glaucoma	2.66e-05	0.000272	CcSEcCtD
Indapamide—Headache—Clonidine—glaucoma	2.65e-05	0.00027	CcSEcCtD
Indapamide—Dyspepsia—Timolol—glaucoma	2.65e-05	0.00027	CcSEcCtD
Indapamide—Asthenia—Betaxolol—glaucoma	2.64e-05	0.00027	CcSEcCtD
Indapamide—CA12—Metabolism—TXN—glaucoma	2.63e-05	0.000449	CbGpPWpGaD
Indapamide—CA9—Metabolism—CA1—glaucoma	2.63e-05	0.000449	CbGpPWpGaD
Indapamide—Decreased appetite—Timolol—glaucoma	2.61e-05	0.000267	CcSEcCtD
Indapamide—Pruritus—Betaxolol—glaucoma	2.6e-05	0.000266	CcSEcCtD
Indapamide—Gastrointestinal disorder—Timolol—glaucoma	2.59e-05	0.000265	CcSEcCtD
Indapamide—Fatigue—Timolol—glaucoma	2.59e-05	0.000265	CcSEcCtD
Indapamide—Pain—Timolol—glaucoma	2.57e-05	0.000262	CcSEcCtD
Indapamide—CA9—Metabolism—CTSA—glaucoma	2.55e-05	0.000434	CbGpPWpGaD
Indapamide—Diarrhoea—Betaxolol—glaucoma	2.52e-05	0.000257	CcSEcCtD
Indapamide—Nausea—Clonidine—glaucoma	2.51e-05	0.000256	CcSEcCtD
Indapamide—Feeling abnormal—Timolol—glaucoma	2.48e-05	0.000253	CcSEcCtD
Indapamide—Gastrointestinal pain—Timolol—glaucoma	2.46e-05	0.000251	CcSEcCtD
Indapamide—Dizziness—Betaxolol—glaucoma	2.43e-05	0.000248	CcSEcCtD
Indapamide—CA9—Metabolism—CA2—glaucoma	2.41e-05	0.00041	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	2.4e-05	0.000408	CbGpPWpGaD
Indapamide—Urticaria—Timolol—glaucoma	2.39e-05	0.000244	CcSEcCtD
Indapamide—Abdominal pain—Timolol—glaucoma	2.38e-05	0.000243	CcSEcCtD
Indapamide—Body temperature increased—Timolol—glaucoma	2.38e-05	0.000243	CcSEcCtD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	2.36e-05	0.000403	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTT1—glaucoma	2.36e-05	0.000402	CbGpPWpGaD
Indapamide—Vomiting—Betaxolol—glaucoma	2.34e-05	0.000239	CcSEcCtD
Indapamide—Rash—Betaxolol—glaucoma	2.32e-05	0.000237	CcSEcCtD
Indapamide—Dermatitis—Betaxolol—glaucoma	2.32e-05	0.000237	CcSEcCtD
Indapamide—Headache—Betaxolol—glaucoma	2.3e-05	0.000235	CcSEcCtD
Indapamide—Hypersensitivity—Timolol—glaucoma	2.21e-05	0.000226	CcSEcCtD
Indapamide—CA7—Metabolism—GSTT1—glaucoma	2.2e-05	0.000375	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTT1—glaucoma	2.2e-05	0.000375	CbGpPWpGaD
Indapamide—Nausea—Betaxolol—glaucoma	2.18e-05	0.000223	CcSEcCtD
Indapamide—Asthenia—Timolol—glaucoma	2.16e-05	0.00022	CcSEcCtD
Indapamide—Pruritus—Timolol—glaucoma	2.13e-05	0.000217	CcSEcCtD
Indapamide—CA4—Metabolism—TXN—glaucoma	2.1e-05	0.000358	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDKN2A—glaucoma	2.1e-05	0.000357	CbGpPWpGaD
Indapamide—Diarrhoea—Timolol—glaucoma	2.06e-05	0.00021	CcSEcCtD
Indapamide—CA12—Metabolism—GSTT1—glaucoma	2.04e-05	0.000348	CbGpPWpGaD
Indapamide—CA2—Metabolism—TXN—glaucoma	2.01e-05	0.000343	CbGpPWpGaD
Indapamide—Dizziness—Timolol—glaucoma	1.99e-05	0.000203	CcSEcCtD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	1.94e-05	0.000331	CbGpPWpGaD
Indapamide—Vomiting—Timolol—glaucoma	1.91e-05	0.000195	CcSEcCtD
Indapamide—Rash—Timolol—glaucoma	1.89e-05	0.000193	CcSEcCtD
Indapamide—Dermatitis—Timolol—glaucoma	1.89e-05	0.000193	CcSEcCtD
Indapamide—Headache—Timolol—glaucoma	1.88e-05	0.000192	CcSEcCtD
Indapamide—CA5A—Metabolism—CYP1B1—glaucoma	1.88e-05	0.00032	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ABCA1—glaucoma	1.88e-05	0.00032	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDKN1B—glaucoma	1.86e-05	0.000316	CbGpPWpGaD
Indapamide—Nausea—Timolol—glaucoma	1.78e-05	0.000182	CcSEcCtD
Indapamide—CA5B—Metabolism—ABCA1—glaucoma	1.76e-05	0.000299	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP1B1—glaucoma	1.76e-05	0.000299	CbGpPWpGaD
Indapamide—CA7—Metabolism—ABCA1—glaucoma	1.76e-05	0.000299	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP1B1—glaucoma	1.76e-05	0.000299	CbGpPWpGaD
Indapamide—CA9—Metabolism—TXN—glaucoma	1.7e-05	0.000289	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTT1—glaucoma	1.63e-05	0.000277	CbGpPWpGaD
Indapamide—CA12—Metabolism—ABCA1—glaucoma	1.63e-05	0.000277	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP1B1—glaucoma	1.63e-05	0.000277	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTT1—glaucoma	1.56e-05	0.000266	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—VEGFA—glaucoma	1.54e-05	0.000263	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTM1—glaucoma	1.5e-05	0.000256	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTM1—glaucoma	1.4e-05	0.000239	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTM1—glaucoma	1.4e-05	0.000239	CbGpPWpGaD
Indapamide—CA5A—Metabolism—MTHFR—glaucoma	1.33e-05	0.000226	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTT1—glaucoma	1.32e-05	0.000224	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTM1—glaucoma	1.3e-05	0.000222	CbGpPWpGaD
Indapamide—CA4—Metabolism—ABCA1—glaucoma	1.3e-05	0.000221	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP1B1—glaucoma	1.3e-05	0.000221	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTT1—glaucoma	1.3e-05	0.000221	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP1B1—glaucoma	1.24e-05	0.000212	CbGpPWpGaD
Indapamide—CA2—Metabolism—ABCA1—glaucoma	1.24e-05	0.000212	CbGpPWpGaD
Indapamide—CA7—Metabolism—MTHFR—glaucoma	1.24e-05	0.000211	CbGpPWpGaD
Indapamide—CA5B—Metabolism—MTHFR—glaucoma	1.24e-05	0.000211	CbGpPWpGaD
Indapamide—CA5A—Metabolism—APOE—glaucoma	1.24e-05	0.000211	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CAV1—glaucoma	1.23e-05	0.000209	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—TP53—glaucoma	1.17e-05	0.000199	CbGpPWpGaD
Indapamide—CA7—Metabolism—APOE—glaucoma	1.15e-05	0.000197	CbGpPWpGaD
Indapamide—CA5B—Metabolism—APOE—glaucoma	1.15e-05	0.000197	CbGpPWpGaD
Indapamide—CA12—Metabolism—MTHFR—glaucoma	1.15e-05	0.000196	CbGpPWpGaD
Indapamide—CA7—Metabolism—CAV1—glaucoma	1.14e-05	0.000195	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CAV1—glaucoma	1.14e-05	0.000195	CbGpPWpGaD
Indapamide—CA12—Metabolism—APOE—glaucoma	1.07e-05	0.000182	CbGpPWpGaD
Indapamide—CA12—Metabolism—CAV1—glaucoma	1.06e-05	0.000181	CbGpPWpGaD
Indapamide—CA9—Metabolism—ABCA1—glaucoma	1.05e-05	0.000179	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP1B1—glaucoma	1.05e-05	0.000179	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTM1—glaucoma	1.04e-05	0.000177	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.03e-05	0.000176	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.02e-05	0.000173	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTM1—glaucoma	9.94e-06	0.000169	CbGpPWpGaD
Indapamide—CA5A—Metabolism—NOS3—glaucoma	9.27e-06	0.000158	CbGpPWpGaD
Indapamide—CA4—Metabolism—MTHFR—glaucoma	9.17e-06	0.000156	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NARFL—glaucoma	9.08e-06	0.000155	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CA5A—glaucoma	9.08e-06	0.000155	CbGpPWpGaD
Indapamide—CA2—Metabolism—MTHFR—glaucoma	8.79e-06	0.00015	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NOS3—glaucoma	8.65e-06	0.000147	CbGpPWpGaD
Indapamide—CA7—Metabolism—NOS3—glaucoma	8.65e-06	0.000147	CbGpPWpGaD
Indapamide—CA4—Metabolism—APOE—glaucoma	8.53e-06	0.000145	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS2—glaucoma	8.48e-06	0.000144	CbGpPWpGaD
Indapamide—CA4—Metabolism—CAV1—glaucoma	8.45e-06	0.000144	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTM1—glaucoma	8.38e-06	0.000143	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTM1—glaucoma	8.25e-06	0.000141	CbGpPWpGaD
Indapamide—CA2—Metabolism—APOE—glaucoma	8.18e-06	0.000139	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	8.14e-06	0.000139	CbGpPWpGaD
Indapamide—CA2—Metabolism—CAV1—glaucoma	8.1e-06	0.000138	CbGpPWpGaD
Indapamide—CA12—Metabolism—NOS3—glaucoma	8.02e-06	0.000137	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS2—glaucoma	7.91e-06	0.000135	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS2—glaucoma	7.91e-06	0.000135	CbGpPWpGaD
Indapamide—CA9—Metabolism—MTHFR—glaucoma	7.41e-06	0.000126	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS2—glaucoma	7.33e-06	0.000125	CbGpPWpGaD
Indapamide—CA9—Metabolism—APOE—glaucoma	6.89e-06	0.000117	CbGpPWpGaD
Indapamide—CA9—Metabolism—CAV1—glaucoma	6.83e-06	0.000116	CbGpPWpGaD
Indapamide—CA4—Metabolism—NOS3—glaucoma	6.39e-06	0.000109	CbGpPWpGaD
Indapamide—CA2—Metabolism—NOS3—glaucoma	6.13e-06	0.000104	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS2—glaucoma	5.85e-06	9.96e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS2—glaucoma	5.61e-06	9.55e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—NOS3—glaucoma	5.17e-06	8.8e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS2—glaucoma	4.72e-06	8.05e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CA1—glaucoma	4.43e-06	7.55e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CTSA—glaucoma	4.29e-06	7.31e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CA2—glaucoma	4.05e-06	6.91e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TXN—glaucoma	2.86e-06	4.87e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTT1—glaucoma	2.21e-06	3.77e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP1B1—glaucoma	1.76e-06	3.01e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ABCA1—glaucoma	1.76e-06	3.01e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTM1—glaucoma	1.41e-06	2.4e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MTHFR—glaucoma	1.25e-06	2.12e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—APOE—glaucoma	1.16e-06	1.98e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CAV1—glaucoma	1.15e-06	1.96e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NOS3—glaucoma	8.7e-07	1.48e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS2—glaucoma	7.95e-07	1.35e-05	CbGpPWpGaD
